Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23084550)

1.

Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study.

Bernink FJ, Timmers L, Diamant M, Scholte M, Beek AM, Kamp O, Marques KM, Denham RN, Chen WJ, Doevendans PA, van Rossum AC, van Royen N, Horrevoets AJ, Appelman Y.

Int J Cardiol. 2013 Jul 15;167(1):289-90. doi: 10.1016/j.ijcard.2012.09.204. Epub 2012 Oct 18. No abstract available.

2.

Do exenatide truly improve the myocardial infarction size?

Woo JS, Kim W.

Int J Cardiol. 2013 Oct 3;168(3):2993. doi: 10.1016/j.ijcard.2013.04.013. Epub 2013 Apr 28. No abstract available.

PMID:
23628300
3.

Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.

Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2252-60. doi: 10.1161/ATVBAHA.113.301586. Epub 2013 Jul 18.

4.

Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.

Lønborg J, Kelbæk H, Vejlstrup N, Bøtker HE, Kim WY, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Terkelsen CJ, Schoos MM, Køber L, Clemmensen P, Treiman M, Engstrøm T.

Circ Cardiovasc Interv. 2012 Apr;5(2):288-95. doi: 10.1161/CIRCINTERVENTIONS.112.968388. Epub 2012 Apr 10.

5.

Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial.

Scholte M, Timmers L, Bernink FJ, Denham RN, Beek AM, Kamp O, Diamant M, Horrevoets AJ, Niessen HW, Chen WJ, van Rossum AC, van Royen N, Doevendans PA, Appelman Y.

Trials. 2011 Nov 8;12:240. doi: 10.1186/1745-6215-12-240.

6.

Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.

Zhu TQ, Zhang Q, Qiu JP, Jin HG, Lu L, Shen J, Zhao LP, Zhang RY, Hu J, Yang ZK, Shen WF.

Int J Cardiol. 2013 May 25;165(3):437-43. doi: 10.1016/j.ijcard.2011.08.082. Epub 2011 Sep 21.

PMID:
21940058
7.

Usefulness of angiotensin-(1-7) to predict myocardial salvage after percutaneous coronary intervention in patients with acute myocardial infarction.

Hao PP, Liu YP, Hou GH, Zhang MX, Chen YG, Zhang Y, Zhang C.

Int J Cardiol. 2013 Sep 20;168(1):614-6. doi: 10.1016/j.ijcard.2013.01.206. Epub 2013 Mar 6. No abstract available.

PMID:
23473823
8.

Effects of erythropoietin administration on iron status in patients with ST-elevation myocardial infarction who underwent successful percutaneous coronary intervention.

Suzuki T, Toba K, Kato K, Ozawa T, Suzuki H, Tomosugi N, Saitoh H, Aizawa Y.

Int J Cardiol. 2013 Aug 20;167(4):1644-5. doi: 10.1016/j.ijcard.2012.11.026. Epub 2012 Nov 23. No abstract available.

PMID:
23182005
9.

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.

Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T.

Eur Heart J. 2012 Jun;33(12):1491-9. doi: 10.1093/eurheartj/ehr309. Epub 2011 Sep 14.

10.

Effects of contemporary management on clinical outcomes in elderly patients with acute myocardial infarction.

Oh JH, Kim C, Yang MJ, An SG, Lee HW, Choi JH, Lee HC, Cha KS, Hong TJ; Korea Acute Myocardial Infarction Registry.

Int J Cardiol. 2013 Sep 20;168(1):572-3. doi: 10.1016/j.ijcard.2013.01.245. Epub 2013 Feb 22. No abstract available.

PMID:
23462633
11.

Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg.

Malmenäs M, Bouchard JR, Langer J.

Clin Ther. 2013 Jun;35(6):795-807. doi: 10.1016/j.clinthera.2013.03.021. Epub 2013 May 1.

PMID:
23642290
12.

Exenatide once weekly in type 2 diabetes mellitus.

Bischoff LA, Jabbour SA, Miller JL.

Expert Opin Pharmacother. 2011 Jun;12(8):1297-1303. doi: 10.1517/14656566.2011.573145. No abstract available.

PMID:
21548720
13.

Exenatide BID and liraglutide QD treatment patterns among type 2 diabetes patients in Germany.

Miller LA, Burudpakdee C, Zagar A, Bhosle M, Reaney M, Schabert VF, Bruhn D.

J Med Econ. 2012;15(4):746-57. doi: 10.3111/13696998.2012.679756. Epub 2012 Apr 3.

PMID:
22443463
14.
15.

Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Direct Inhibition of delta-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) Investigators, Bates E, Bode C, Costa M, Gibson CM, Granger C, Green C, Grimes K, Harrington R, Huber K, Kleiman N, Mochly-Rosen D, Roe M, Sadowski Z, Solomon S, Widimsky P.

Circulation. 2008 Feb 19;117(7):886-96. doi: 10.1161/CIRCULATIONAHA.107.759167. Epub 2008 Feb 4.

16.

Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).

Singh HS, Dangas GD, Guagliumi G, Yu J, Witzenbichler B, Kornowski R, Grines C, Gersh B, Dudek D, Mehran R, Stone GW.

Am J Cardiol. 2012 Oct 1;110(7):940-7. doi: 10.1016/j.amjcard.2012.05.026. Epub 2012 Jun 28.

PMID:
22748356
17.

Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).

Rene AG, Généreux P, Ezekowitz M, Kirtane AJ, Xu K, Mehran R, Brener SJ, Stone GW.

Am J Cardiol. 2014 Jan 15;113(2):236-42. doi: 10.1016/j.amjcard.2013.09.016. Epub 2013 Oct 3.

PMID:
24176066
18.

DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide.

Wysham C, Bergenstal R, Malloy J, Yan P, Walsh B, Malone J, Taylor K.

Diabet Med. 2011 Jun;28(6):705-14. doi: 10.1111/j.1464-5491.2011.03301.x.

19.

Exenatide for once-weekly administration.

[No authors listed]

Drug Ther Bull. 2012 Jul;50(7):78-80. doi: 10.1136/dtb.2012.06.0115.

PMID:
22789767
20.

Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Porto I, De Maria GL, Leone AM, Dato I, D'Amario D, Burzotta F, Niccoli G, Trani C, Biasucci LM, Bolognese L, Crea F.

Am J Cardiol. 2013 Sep 15;112(6):782-91. doi: 10.1016/j.amjcard.2013.04.056. Epub 2013 Jun 6.

PMID:
23746481
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk